Search Results 281-290 of 16885 for what is vedolizumab
... Crohn's disease whom she has recruited through a separate study. Dr. Pasha's goal is to identify specific antibodies against human proteins in patients with ...
To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...
... ulcerative colitis, and flare-ups of multiple sclerosis. Betamethasone sodium phosphate and betamethasone acetate combination is a corticosteroid (cortisone ...
Ozanimod will be administered orally to pediatric participants with moderate to severe active Ulcerative Colitis who have had an inadequate response to ...
He is American Board Certified in Gastroenterology with specialty interest and fellowship training in Crohn's disease and ulcerative colitis, the two main ...
This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...
As many as 26% of people with Crohn's disease will develop perianal fistulas. Most often, it starts with an infection within the anal gland and often progresses ...
The investigators propose to study the safety of autologous mesenchymal stromal cell transfer using a biomatrix (the Gore Bio-A Fistula Plug) in a Phase I study ...
A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Moderate-to-Severe, Active Crohn's Disease. Print details.
May 14, 2010. Dear Mayo Clinic: When I quit smoking cigarettes four years ago, I discovered I have ulcerative colitis. After a few years of only moderate ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.